Research tools and consumables stocks post mixed Q1, Waters Corporation leads with 91.5% revenue surge

Earnings
โดย StockStory·Read original
Summary · why it matters

The 10 research tools and consumables stocks tracked by StockStory reported mixed first-quarter results, with aggregate revenues beating analyst consensus by 1.3% and next-quarter revenue guidance coming in 2% above expectations. Thermo Fisher posted revenues of $11.01 billion, up 6.2% year on year and exceeding estimates by 1.5%, though its stock fell 5.2% after the report. Waters Corporation delivered the strongest performance among peers, with revenues of $1.27 billion surging 91.5% year on year and beating estimates by 4.5%, driving a 22.3% stock gain. Revvity reported revenues of $686.9 million, up 9.3% but missing estimates by 2.6%, while Bio-Techne's revenues declined 1.5% to $311.4 million, lagging expectations by 1.6%. Agilent Technologies posted revenues of $1.84 billion, up 10% and topping estimates by 1.9%, with its stock rising 13.6%.

Impact on stocks 5

Biotech & Genomic Medicine± Mixed · 5 stocks
Agilent Technologies Inc
A
▲ PositiveCapitalrelevance

Agilent reported Q1 revenues up 10% and above estimates, driving stock up 13.6%.

Revvity Inc.
RVTY
▼ NegativeCapitalrelevance

Revvity reported revenues up 9.3% but missed estimates by 2.6%.

Bio-Techne Corp
TECH
▼ NegativeCapitalrelevance

Bio-Techne's revenues declined 1.5% and lagged expectations by 1.6%.

Waters Corporation
WAT
▲ PositiveCapitalrelevance

Waters Corporation revenues surged 91.5% and beat estimates by 4.5%, driving stock up 22.3%.